Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties

International Journal of Pharmaceutics

Volumn 367, Issue 1-2, 2009, Pages 86-96

  Tajber, L ^a   Corrigan, O I ^a   Healy, A M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amorphous; Budesonide; Factorial design; Formoterol fumarate; Inhalation; Spray drying

Indexed keywords

ALCOHOL; BUDESONIDE; FORMOTEROL FUMARATE; WATER;

AIRFLOW; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); FACTORIAL DESIGN; FLOW RATE; IN VITRO STUDY; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SPRAY DRYING; TEMPERATURE;

ANTI-ASTHMATIC AGENTS; BUDESONIDE; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG COMBINATIONS; DRUG COMPOUNDING; ETHANOLAMINES; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHASE TRANSITION; RESEARCH DESIGN; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 58249113923     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.029     Document Type: Article

References (33)

1. Billon A., Bataille B., Cassanas G., and Jacob M. Development of spray-dried acetaminophen microparticles using experimental designs. Int. J. Pharm. 203 (2000) 159-168
2. Bosquillon C., Lombry C., Préat V., and Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Control. Release 70 (2001) 329-339
3. Broadhead J., Rouan S.K.E., Hau I., and Rhodes C.T. The effect of process and formulation variables on the properties of spray-dried beta-galactosidase. J. Pharm. Pharmacol. 46 (1994) 458-467
4. Byron P.R., Peart J., and Staniforth J.N. Aerosol electrostatics. I. Properties of fine powders before and after aerosolization by dry powder inhalers. Pharm. Res. 14 (1997) 698-705
5. Carr Jr. R.L. Classifying flow properties of solids. Chem. Eng. 72 (1965) 69-72
6. Chawla A., Taylor K.M.G., Newton J.M., and Johnson M.C.R. Production of spray-dried salbutamol sulfate for use in dry powder aerosol formulation. Int. J. Pharm. 108 (1994) 233-240
7. Chew N.Y.K., Bagster D.F., and Chan H.K. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int. J. Pharm. 206 (2000) 75-83
8. Corrigan D.O., Corrigan O.I., and Healy A.M. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Int. J. Pharm. 322 (2006) 22-30
9. Crosby E.J., and Marshall Jr. W.R. Effects of drying conditions on properties of spray-dried particles. Chem. Eng. Prog. 54 (1958) 56-63
10. Davies P.J., Hanlon G.W., and Molyneux A.J. An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified 'Kirk Lung'. J. Pharm. Pharmacol. 28 (1976) 908-911
11. Elversson J., Millqvist-Fureby A., Alderborn G., and Elofsson U. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J. Pharm. Sci. 92 (2003) 900-910
12. French D.L., Edwards D.A., and Niven R.W. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aerosol Sci. 27 (1996) 769-783
13. Goula A.M., and Adamopoulos K.G. Spray drying of tomato pulp: effect of feed concentration. Dry. Technol. 22 (2004) 2309-2330
14. Hallworth G.W., and Westmoreland D.G. The twin impinger - a simple device for assessing the delivery of drugs from metered dose pressurized aerosolinhalers. J. Pharm. Pharmacol. 39 (1987) 966-972
15. Hancock B.C., Shalaev E.Y., and Shamblin S.L. Polyamorphism: a pharmaceutical science perspective. J. Pharm. Pharmacol. 54 (2002) 1151-1152
16. Hickey A.J., Concessio N.M., Van Oort M.M., and Platz R.M. Factors influencing the dispersion of dry powders as aerosols. Pharm. Technol. 18 (1994) 58-82
17. Iida K., Hayakawa Y., Okamoto H., Danjo K., and Leuenberger H. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier. Chem. Pharm. Bull. 49 (2001) 1326-1330
18. Kawashima Y., Serigano T., Hino T., Yamamoto H., and Takeuchi H. Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200). Int. J. Pharm. 173 (1998) 243-251
19. Maa Y.F., Nguyen P.A., Sit K., and Hsu C.C. Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation. Biotechnol. Bioeng. 60 (1998) 301-309
20. Masters K. Spray drying handbook. 4th ed. (1985), The Pitman Press, Bath
21. Mura P., Cirri M., Faucci M.T., Gines-Dorado J.M., and Bettinetti G.P. Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. J. Pharm. Biomed. Anal. 30 (2002) 227-237
22. Nath S., and Satpathy G.R. A systematic approach for investigation of spray drying processes. Dry. Technol. 16 (1998) 1173-1193
23. Newell H.E., Buckton G., Butler D.A., Thielmann F., and Williams D.R. The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose. Pharm. Res. 18 (2001) 662-666
24. Ohta M., and Buckton G. A study of differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited diffent physical stabilities. Int. J. Pharm. 289 (2005) 31-38
25. Prinn K.B., Costantino H.R., and Tracy M. Statistical modelling of protein spray drying at the lab scale. AAPS PharmSciTech 3 (2002) E4
26. Ståhl K., Claesson M., Lilliehorn P., Linden H., and Backstrom K. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int. J. Pharm. 233 (2002) 227-237
27. Steckel H., and Brandes H.G. A novel spray-drying technique to produce low density particles for pulmonary delivery. Int. J. Pharm. 278 (2004) 187-195
28. Steele D.F., Young P.M., Price R., Smith T., Edge S., and Lewis D. The potential use of Raman mapping to investigate in vitro deposition of combination pressurized metered-dose inhalers. AAPS J. 6 (2004) article 32
29. Tajber L., Corrigan D.O., Corrigan O.I., and Healy A.M. Spray drying of budesonide, formoterol fumarate and their composites-I. Physicochemical characterisation. Int. J. Pharm. 367 (2009) 79-85
30. Taki M., Zeng X.M., Oliver M., Marriott C., and Martin G.P. A comparison of the in-vitro deposition profiles of drugs from a combination dry powder inhaler (DPI) using the Multistage Liquid Impinger (MSLI). Inhalation 2007 (2007), University of Bath, UK
31. Voss A., and Finlay W.H. Deagglomeration of dry powder pharmaceutical aerosols. Int. J. Pharm. 248 (2002) 39-50
32. Woolfe, A.J., Zing, X.M., Langford, A., 2002. Spray dried powders for pulmonary or nasal administration. US Patent Application 2002081266.
33. Zetterström O., Buhl R., Mellem H., Perpiñá M., Hedman J., O'Neill S., and Ekström T. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur. Respir. J. 18 (2001) 262-268